Keyphrases
Histone Deacetylase Inhibitor (HDACi)
100%
Apoptosis
100%
Osteosarcoma Cells
100%
AR-42
100%
Cell Viability
37%
Osteosarcoma
37%
Canine Osteosarcoma
37%
Suberoylanilide Hydroxamic Acid
37%
Doxorubicin
25%
Human Osteosarcoma
25%
Potent Inhibitor
25%
Caspase-3
25%
AKT Pathway
25%
Western Blotting
12%
Older Adults
12%
Preclinical Evaluation
12%
Histone Acetylation
12%
Anticancer Agents
12%
Chemotherapy
12%
Osteoblast
12%
Cell Survival
12%
Synergistic Effect
12%
Enzymatic Activity
12%
Acid Activation
12%
Signaling Molecules
12%
Pet Dogs
12%
Cancer Mortality
12%
Cancer Causes
12%
Large Animal Model
12%
Induced Cell Death
12%
Downstream Signaling
12%
Akt Phosphorylation
12%
Current Therapies
12%
Caspase Cleavage
12%
Pleiotropic Effects
12%
Survival Signaling
12%
Apoptotic Activity
12%
Drug-induced Apoptosis
12%
Apoptotic Response
12%
Chemotherapeutic Interventions
12%
Human Osteosarcoma Cells
12%
Primary Bone Tumor
12%
Limb-sparing Surgery
12%
Intrinsic Mitochondrial Pathway
12%
Doxorubicin Treatments
12%
Inhibitor Treatment
12%
Histone Deacetylase Activity
12%
Real Need
12%
Osteosarcoma Cell Lines
12%
Pharmacology, Toxicology and Pharmaceutical Science
Osteosarcoma
100%
Histone Deacetylase Inhibitor
100%
Doxorubicin
37%
Cell Viability
37%
Vorinostat
37%
Caspase 3
25%
Histone Deacetylase
25%
Pet Animal
12%
Chemotherapy
12%
Western Blot
12%
Fluorescence Activated Cell Sorting
12%
Malignant Neoplasm
12%
Histone
12%
Bone Tumor
12%
Caspase
12%
Bone Cancer
12%
Anticancer Drug
12%
Veterinary Science and Veterinary Medicine
Osteosarcoma
100%
Doxorubicin
42%
Dog
28%
Primary Bone
14%
Osteoblast
14%
Bone Tumor
14%
Pet Animal
14%
Cancer
14%
Canine Osteosarcoma
14%
Limb Sparing
14%